AAM
GMAB icon

Advisors Asset Management’s Genmab GMAB Stock Holding History

Advisors Asset Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,859
Closed -$36.4K – 1501
2025
Q1 		$36.4K Sell
1,859
-960
-34% -$20.1K ﹤0.01% 1314
2024
Q4 		$58.8K Sell
2,819
-3,400
-55% -$74.7K ﹤0.01% 1296
2024
Q3 		$152K Sell
6,219
-622
-9% -$16.6K ﹤0.01% 1152
2024
Q2 		$172K Sell
6,841
-3,377
-33% -$95.7K ﹤0.01% 1139
2024
Q1 		$306K Sell
10,218
-2,284
-18% -$67.1K 0.01% 1042
2023
Q4 		$398K Sell
12,502
-3,096
-20% -$97.2K 0.01% 964
2023
Q3 		$550K Sell
15,598
-164
-1% -$6.25K 0.01% 878
2023
Q2 		$599K Sell
15,762
-2,996
-16% -$119K 0.01% 888
2023
Q1 		$708K Sell
18,758
-8,832
-32% -$339K 0.01% 856
2022
Q4 		$1.17M Sell
27,590
-18,737
-40% -$772K 0.02% 685
2022
Q3 		$1.49M Sell
46,327
-6,694
-13% -$235K 0.03% 583
2022
Q2 		$1.72M Sell
53,021
-14,030
-21% -$455K 0.03% 570
2022
Q1 		$2.43M Sell
67,051
-14,859
-18% -$510K 0.04% 525
2021
Q4 		$3.24M Buy
81,910
+18,097
+28% +$755K 0.05% 449
2021
Q3 		$2.79M Buy
63,813
+15,823
+33% +$710K 0.04% 472
2021
Q2 		$1.96M Buy
47,990
+6,429
+15% +$248K 0.03% 605
2021
Q1 		$1.36M Buy
41,561
+16,032
+63% +$603K 0.02% 719
2020
Q4 		$1.04M Buy
25,529
+11,925
+88% +$446K 0.02% 769
2020
Q3 		$498K Buy
13,604
+4,449
+49% +$161K 0.01% 921
2020
Q2 		$310K Buy
+9,155
New +$249K 0.01% 1052
2020
Q1 		– Sell
-1,721
Closed -$38K – 1521
2019
Q4 		$38K Buy
+1,721
New +$37.6K ﹤0.01% 1422

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Advisors Asset Management's GMAB Position: Q2 2025 in Review

Advisors Asset Management sold out of Genmab (GMAB) in Q2 2025, closing a stake of 1,859 shares — an estimated $36.4K sold.

Advisors Asset Management first reported a position in GMAB in Q4 2019 and held it in 21 quarters. The position peaked at $3.24M in Q4 2021. 217 funds tracked by Wall St. Rank hold GMAB as of Q2 2025.

  • Advisors Asset Management reported no remaining Genmab position as of Q2 2025 after selling out during the quarter.
  • Advisors Asset Management sold 1,859 Genmab shares in Q2 2025, an estimated $36.4K.
  • Advisors Asset Management first reported a position in Genmab in Q4 2019 and held it in 21 quarters.
  • Advisors Asset Management's Genmab position peaked at $3.24M in Q4 2021.
  • 217 funds tracked by Wall St. Rank held Genmab as of Q2 2025.

Based on Advisors Asset Management's 13F filing for Q2 2025, filed 12 Aug 2025.